Securities code: Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) securities abbreviation: Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) Announcement No.: 2022037 Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534)
Announcement on resignation of directors and senior managers
The board of directors of Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) (hereinafter referred to as “the company” or “the company”) received the written resignation report submitted by Mr. Zhang Jinde, the director of the company, and Mr. Zhang Fan, the deputy general manager and chief financial officer of the company on April 23, 2022. Mr. Zhang Jinde no longer served as a director of the company due to personal work adjustment, applied for resignation as a director of the Fourth Board of directors of the company, and resigned as a member of the remuneration and assessment committee of the Fourth Board of directors at the same time, and still worked in the company after resignation; Mr. Zhang Fan applied to resign from the post of deputy general manager and chief financial officer of the company due to his personal job change. After his resignation, he will no longer work in the company.
As of the disclosure date of this announcement, Mr. Zhang Jinde holds 1170045 shares of the company, accounting for 0.39% of the total share capital of the company. The original term of office of his director was from December 30, 2020 to December 29, 2023; Mr. Zhang Fan holds 368277 shares of the company, accounting for 0.12% of the total share capital of the company. The original term of office of his deputy general manager and chief financial officer was from December 30, 2020 to December 29, 2023. In accordance with the relevant provisions of the Shenzhen Stock Exchange GEM Listing Rules, Shenzhen Stock Exchange listed companies self regulatory guidelines No. 2 – standardized operation of GEM listed companies, detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of Listed Companies in Shenzhen Stock Exchange, and the rules for the management of shares held by directors, supervisors and senior managers of listed companies and their changes, If Dong Jiangao resigns before the expiration of his term of office, he shall continue to abide by the following restrictive provisions during the term of office determined at the time of taking office and within six months after the expiration of his term of office: “(1) the shares transferred every year shall not exceed 25% of the total shares of the company held by him; (2) the shares of the company held by him shall not be transferred half a year after his resignation; (3) other provisions on the transfer of shares of Dong Jiangao in the company law.” In addition, Mr. Zhang Jinde and Mr. Zhang Fan promised before the listing of the company: “The annual transfer amount of the company’s shares held by him during his term of office shall not exceed 25% of the total number of shares held by him directly or indirectly; he shall not transfer the shares held by him directly or indirectly within half a year after his resignation; if the shares held by him are reduced within two years after the expiration of the lock-in period, the reduction price shall not be lower than the issue price; the above commitments shall not be invalidated due to his change of position or resignation.”
According to the company law, the articles of association and other relevant provisions, Mr. Zhang Jinde’s resignation will not cause the number of the board of directors of the company to be lower than the legal minimum, and will not affect the normal operation of the board of directors of the company. The resignation reports of Mr. zhangjinde and Mr. Zhangfan shall take effect from the date of delivery to the board of directors of the company.
The board of directors of the company fully respects the wishes of Mr. Zhang Jinde and Mr. Zhang Fan and accepts their resignation. Mr. Zhang Jinde and Mr. Zhang fan are diligent, loyal, honest and conscientious during their tenure in the company. The company expresses its heartfelt thanks to Mr. Zhang Jinde and Mr. Zhang Fan for their contributions to the development of the company.
It is hereby announced.
Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) board of directors April 24, 2022
